30.1 C
Delhi
Friday, September 19, 2025

Alembic Pharma receives USFDA final approval for Fluorouracil Injection

Date:

Share post:

Donate-GC-Razorpay

Mumbai: Alembic Pharma on Monday said it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Fluorouracil Injection, 2.5 g/50 mL (50 mg/mL), of Spectrum Pharmaceuticals, Inc. (Spectrum). Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum, adenocarcinoma of the breast, gastric adenocarcinoma and pancreatic adenocarcinoma. Refer to our label for full indication.

Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Vial, has an estimated market size of US$ 5 million for twelve months ending Dec 2022 according to IQVIA.

Related articles

The Fractured Geopolitics of the Middle East: How Internal Divisions and External Interventions Are Degrading the Region

Introduction: A Region at War with ItselfThe Middle East and West Asia present a paradox of immense...

America’s $35 Trillion Debt: Crypto Cloud Scam to Reset the Dollar

In the corridors of geopolitical strategy, there are whispers louder than any official announcement, whispers that reveal not...

The American Military in Bangladesh: Quiet Landings, Loud Questions

The quiet arrival of American boots on Bangladeshi soil has raised eyebrows not just in Dhaka but in...

Qatar’s Blood Money: How Doha Bankrolled Hamas and Fueled the October 7 Massacre

 Since 2012, Qatar has positioned itself as Gaza’s saviour while quietly acting as its executioner. The numbers are...